These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 22196485)

  • 1. Spinal muscular atrophy: a clinical and research update.
    Markowitz JA; Singh P; Darras BT
    Pediatr Neurol; 2012 Jan; 46(1):1-12. PubMed ID: 22196485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spinal muscular atrophies.
    Darras BT
    Pediatr Clin North Am; 2015 Jun; 62(3):743-66. PubMed ID: 26022173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA).
    Wirth B
    Hum Mutat; 2000; 15(3):228-37. PubMed ID: 10679938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic strategies for the treatment of spinal muscular atrophy.
    Cherry JJ; Androphy EJ
    Future Med Chem; 2012 Sep; 4(13):1733-50. PubMed ID: 22924510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spinal muscular atrophy: recent advances and future prospects.
    Nicole S; Diaz CC; Frugier T; Melki J
    Muscle Nerve; 2002 Jul; 26(1):4-13. PubMed ID: 12115944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmission ratio distortion in the spinal muscular atrophy locus: data from 314 prenatal tests.
    Botta A; Tacconelli A; Bagni I; Giardina E; Bonifazi E; Pietropolli A; Clementi M; Novelli G
    Neurology; 2005 Nov; 65(10):1631-5. PubMed ID: 16301493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal muscular atrophy: molecular genetics and diagnostics.
    Ogino S; Wilson RB
    Expert Rev Mol Diagn; 2004 Jan; 4(1):15-29. PubMed ID: 14711346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal muscular atrophy: from gene discovery to clinical trials.
    Nurputra DK; Lai PS; Harahap NI; Morikawa S; Yamamoto T; Nishimura N; Kubo Y; Takeuchi A; Saito T; Takeshima Y; Tohyama Y; Tay SK; Low PS; Saito K; Nishio H
    Ann Hum Genet; 2013 Sep; 77(5):435-63. PubMed ID: 23879295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spinal muscular atrophy: from animal model to clinical trial.
    Zanoteli E; Maximino JR; Conti Reed U; Chadi G
    Funct Neurol; 2010; 25(2):73-9. PubMed ID: 20923604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and functional analysis of intragenic SMN1 mutations in patients with spinal muscular atrophy.
    Sun Y; Grimmler M; Schwarzer V; Schoenen F; Fischer U; Wirth B
    Hum Mutat; 2005 Jan; 25(1):64-71. PubMed ID: 15580564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SMN oligomerization defect correlates with spinal muscular atrophy severity.
    Lorson CL; Strasswimmer J; Yao JM; Baleja JD; Hahnen E; Wirth B; Le T; Burghes AH; Androphy EJ
    Nat Genet; 1998 May; 19(1):63-6. PubMed ID: 9590291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospects for the gene therapy of spinal muscular atrophy.
    Passini MA; Cheng SH
    Trends Mol Med; 2011 May; 17(5):259-65. PubMed ID: 21334976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal muscular atrophy: newborn and carrier screening.
    Prior TW
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):23-36, Table of Contents. PubMed ID: 20494255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal muscular atrophy: state-of-the-art and therapeutic perspectives.
    Wirth B
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Jun; 3(2):87-95. PubMed ID: 12215230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular basis of spinal muscular atrophy: th SMN gene].
    Tizzano E; Baiget M
    Neurologia; 2000 Nov; 15(9):393-400. PubMed ID: 11195146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular genetic basis of proximal spinal muscular atrophy and experience in its pharmaceutical treatment].
    Baranov VS; Kiselev AV; Vakharlovskiĭ VG; Zhelezniakova GIu; Komantsev VN; Malysheva OV; Glotov AS; Ivashchenko TE; Baranov AN
    Genetika; 2008 Oct; 44(10):1325-37. PubMed ID: 19062530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy.
    Thurmond J; Butchbach ME; Palomo M; Pease B; Rao M; Bedell L; Keyvan M; Pai G; Mishra R; Haraldsson M; Andresson T; Bragason G; Thosteinsdottir M; Bjornsson JM; Coovert DD; Burghes AH; Gurney ME; Singh J
    J Med Chem; 2008 Feb; 51(3):449-69. PubMed ID: 18205293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trials in spinal muscular atrophy.
    Darras BT; Kang PB
    Curr Opin Pediatr; 2007 Dec; 19(6):675-9. PubMed ID: 18025935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges and opportunities in clinical trials for spinal muscular atrophy.
    Hirtz D; Iannaccone S; Heemskerk J; Gwinn-Hardy K; Moxley R; Rowland LP
    Neurology; 2005 Nov; 65(9):1352-7. PubMed ID: 16275820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Animal models of spinal muscular atrophy.
    Schmid A; DiDonato CJ
    J Child Neurol; 2007 Aug; 22(8):1004-12. PubMed ID: 17761656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.